Privacy Statement   Terms & Conditions   Sitemap  
  Diseases   Research   About us  
Clinical Development Product Pipeline How Vaccines work Glossary Events

  Advanced vaccines for a healthier future

Baxter Vaccines’ guiding principle is that everything we do should make a real contribution to improving health, either by providing protection where none was previously available, or by offering a meaningful improvement over existing vaccines.

 » Printversion

  » find


Baxter Receives EMEA Positive Opinion for CELVAPAN, the First Cell Culture-based Pandemic Flu Vaccine
» read more

The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine
» read more

U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSC´s DVC and Baxter
» read more

Baxter Vaccines Industriestrasse 67, A-1221 Wien, Tel: +43-1-20100,